1
Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:March 8, 2024Recruiting